The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
- PMID: 30385601
- DOI: 10.1183/13993003.00694-2018
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Conflict of interest statement
Conflict of interest: R. Beasley reports grants and personal fees from Health Research Council of New Zealand, AstraZeneca and GlaxoSmithKline, and grants from Genentech, all outside the submitted work. Conflict of interest: G. Bird has nothing to disclose. Conflict of interest: J. Harper has nothing to disclose. Conflict of interest: M. Weatherall has nothing to disclose.
Comment in
-
Asthma paradoxes: time for a new approach across the spectrum of asthma severity.Eur Respir J. 2019 Apr 4;53(4):1802329. doi: 10.1183/13993003.02329-2018. Print 2019 Apr. Eur Respir J. 2019. PMID: 30948505 No abstract available.
-
Asthma paradoxes: time for a new approach across the spectrum of asthma severity.Eur Respir J. 2019 Apr 4;53(4):1900218. doi: 10.1183/13993003.00218-2019. Print 2019 Apr. Eur Respir J. 2019. PMID: 30948506 No abstract available.
Comment on
-
The paradoxes of asthma management: time for a new approach?Eur Respir J. 2017 Sep 9;50(3):1701103. doi: 10.1183/13993003.01103-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28889114 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical